BAGSVAERD, DENMARK–(EMWNews – August 11, 2008) – Novo Nordisk A/S – Share repurchase programme

On 31 January 2008 Novo Nordisk initiated its share repurchase

programme in accordance with the provisions of the European

Commission’s regulation no 2273/2003 of 22 December 2003, also

referred to as the Safe Harbour rules.

Under the programme Novo Nordisk has repurchased B shares for an

amount of DKK 2 billion in the period from 31 January 2008 to 6

August 2008. The programme thereby ended on 6 August 2008.

Since the announcement as of 4 August 2008, the following

transactions have been made under the programme:

Number of Average Transaction

shares purchase price value, DKK

Accumulated, last 6,095,407 1,932,455,699

announcement

4 August 2008 70,000 310.7800 21,754,600

5 August 2008 65,700 310.2920 20,386,184

6 August 2008 80,800 313.9800 25,369,584

Accumulated, 2008 6,311,907 1,999,966,068

With the transactions stated above, Novo Nordisk owns a total of

18,015,430 treasury shares, corresponding to 2.8% of the share

capital. The total amount of shares in the company is 634,000,000

including treasury shares.

Novo Nordisk is a healthcare company and a world leader in diabetes

care. In addition, Novo Nordisk has a leading position within areas

such as haemostasis management, growth hormone therapy and hormone

replacement therapy. Novo Nordisk manufactures and markets

pharmaceutical products and services that make a significant

difference to patients, the medical profession and society. With

headquarters in Denmark, Novo Nordisk employs approximately 26,300

employees in 80 countries, and markets its products in 179 countries.

Novo Nordisk’s B shares are listed on the stock exchanges in

Copenhagen and London. Its ADRs are listed on the New York Stock

Exchange under the symbol ‘NVO’. For more information, visit

novonordisk.com.

Further information:

Media: Investors:

Elin K Hansen Mads Veggerby Lausten

Tel: (+45) 4442 3450 Tel: (+45) 4443 7919

[email protected] [email protected]

Hans Rommer

Tel: (+45) 4442 4765

[email protected]

In North America:

Sean Clements

Tel: (+1) 609 514 8316

[email protected]

Company Announcement no 50 / 2008

Copyright © Hugin AS 2008. All rights reserved.